top of page
  • Jonathan Poyer

Sanofi Enters the M&A Game with a $1.7B Acquisition





Continued up and down performance for the market into the week ending January 19th. Sanofi jumped into the M&A game with a $1.7B acquisition of Inhibrx:


Week Ending January 19th, 2024


  • Biotech: 6 Transactions (6 Follow-Ons) totaling just over $800 Million

  • Med Tech: No Current Week Transactions


2024 YTD:


  • 18 Biotech transactions totaling just under $3 Billion v. 2023: 4 Biotech transaction totalings just under $600 Million

  • 1 Med Tech transaction totaling $50 Million v. 2023: 0 Med Tech transactions


Private Transactions:


  • Biotech: 13 US Transactions / 9 European Transactions

  • Med Tech: 9 US Transactions / 4 European Transaction


M&A Deals:


  • Sanofi acquired Inhibrx for $1.7B or $30/share

14 views0 comments
bottom of page